Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FEQBZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency (DLA) for the supply of Jakafi 10 mg tablets in quantities of 60. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and carries no set-aside designation. This award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to issue delivery orders for pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group's federal contracting portfolio demonstrates consistent success in supplying specialty pharmaceutical products to military healthcare systems. The company has established itself as a critical supplier within the federal pharmaceutical supply chain through its comprehensive distribution of branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for Jakafi—a specialty pharmaceutical used in the treatment of certain blood disorders and myelofibrosis—aligns with the company's established expertise in providing oncology and specialty medications to DoD healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FEQBZ?
SPE2DB25FEQBZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FEQBZ worth?
The government has obligated $12,116 on SPE2DB25FEQBZ.
Is contract SPE2DB25FEQBZ an order under another contract?
Yes. SPE2DB25FEQBZ is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQBZ competed?
The extent of competition for SPE2DB25FEQBZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award